483
Southern Sales & Services Inc.Southern Sales & Services Inc. – FDA 483, Aug 7, 2025
Record Details
An FDA inspection of Southern Sales & Services Inc., an OTC drug manufacturer and repacker in Fort Lauderdale, FL, revealed significant deficiencies in their quality system. The firm failed to follow its written stability testing program, did not conduct complete annual product reviews, and lacked an adequate continuous CGMP training program for employees, including production personnel. These issues indicate a lack of robust quality control and compliance with good manufacturing practices.
View Company Profile
ID · ff54655e-d03e-4454-b405-0795ecde0648
Other documents for Southern Sales & Services Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.